New York State Common Retirement Fund’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Buy
+9,200
New +$213K ﹤0.01% 2283
2025
Q2
Sell
-900
Closed -$1.94K 3361
2025
Q1
$1.94K Hold
900
﹤0.01% 3154
2024
Q4
$3.81K Hold
900
﹤0.01% 3151
2024
Q3
$10.3K Sell
900
-8,600
-91% -$105K ﹤0.01% 3105
2024
Q2
$102K Buy
+9,500
New +$124K ﹤0.01% 2810

Other funds holding ANRO

New York State Common Retirement Fund's ANRO Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 9,200 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #2283 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in ANRO as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in ANRO in Q2 2024 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • New York State Common Retirement Fund held 9,200 shares of Alto Neuroscience worth $243K as of Q2 2026.
  • Alto Neuroscience was a new New York State Common Retirement Fund position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2283 holding.
  • New York State Common Retirement Fund first reported a position in Alto Neuroscience in Q2 2024 and has held it in 5 quarters since.
  • 12 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.